How is yervoy dosage adjusted for underweight patients?

How is Yervoy (ipilimumab) dosing adjusted for underweight patients?

Based on the provided information, there are no specific instructions to adjust Yervoy dosing for underweight patients. Yervoy is dosed by body weight, but the standard dosing guidance in the provided material does not include a separate “underweight” dose-reduction or tapering rule. [1]

What dosing rule does Yervoy use instead of “underweight” adjustments?

The provided information indicates Yervoy dosing is weight-based, without a special adjustment category for low body weight. That means clinicians follow the standard weight-based regimen rather than applying an additional underweight-specific modification. [1]

What should patients or caregivers do if a dose seems high for low body weight?

The provided information does not describe any alternative dosing algorithm for underweight patients. If there’s concern about low body weight, the appropriate next step is to confirm the calculated dose with the prescribing clinician or oncology team using the patient’s actual weight, since Yervoy dosing is tied to body weight in the available guidance. [1]

Are there any special risks in low body weight that change dosing?

The provided information does not state that low body weight itself changes safety or triggers a different dosing strategy for Yervoy. It only supports that the dose is based on body weight, with no underweight-specific adjustment described. [1]

Sources

[1] https://www.drugs.com/dosage/yervoy.html